mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
5e-14 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
1e-12 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-11 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.34 |
6e-07 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.27 |
7e-07 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-06 |